Monday, June 27, 2011

Genentech cancer deal kicks off BIO convention

Now this is the way to get this BIO party started.
South San Francisco biotech powerhouse Genentech is buying into a preclinical cancer-fighting program from Forma Therapeutics of Cambridge, Mass. As it turns out, Genentech’s partnering chief, James Sabry, is on my talk-to list today, the first day of the Biotechnology Industry Organization convention in Washington, D.C.

No comments:

Post a Comment